Belhaven Biopharma

Developer of needle-free nasal spray for anaphylaxis and severe allergic reactions

placeRaleigh, North Carolina, United States calendar_todayFounded 2020 groups4 employees language belhavenbio.com

Innovation

8 patent families (5 granted) — focus: Human necessities; filing pace accelerating. Cited 1,222 times.

YearFilings
20222
20233
20245
20253
20262

Social engagement

Social engagement: 2.1K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Accelerator & incubator1100%

Recent activity

29 Jan 2026
Product launch
Nasdepi®
17 Nov 2025
Event
RTP180: Allergies & Allergens event
Coming soon